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Human physical performance is strongly inﬂuenced by genetic factors. Research focused on exercise at the genetic or genomic level has typically involved investigations of genes that affect quantitative measures known to be directly inﬂuenced by exercise (e.g., muscle mass, bone density, and so forth). No gene has yet been identiﬁed for physical activity level, although genes related to metabolic rate might predispose an individual to be active or inactive. One of that genes is ANGIOTENSIN CONVERTING ENZYME (ACE).
A variation in the structure of the human angiotensin I-converting enzyme (ACE) gene has been reported in which the insertion (I) variant is associated with lower ACE levels than the deletion (D) gene. The deletion (D) allele of the gene for angiotensin-converting enzyme (ACE) is associated with higher plasma and tissue levels of the enzyme and has also been related to a variety of cardiovascular complications, particularly myocardial infarction. ANGIOTENSIN I-CONVERTING ENZYME (ACE) is a widely expressed enzyme whose physiological function is to convert angiotensin I to angiotensin II and to inactivate bradykinin and tachykinins. There is a 287-bp insertion (I)/deletion (D) polymorphism in intron 16 of the ACE gene that occurs commonly and that accounts for a substantial portion of the variance in serum ACE levels, with the highest mean levels of serum ACE occurring in subjects with genotype DD and the lowest in subjects with genotype II. 
Epidemiological research has shown that regular physical activity has protective effects for several chronic diseases, including coronary heart disease (CHD), hypertension (HT), non-insulin-dependent diabetes mellitus, and osteoporosis, whereas low levels of physical ﬁtness are associated with increased all-causes mortality rates. The angiotensin-converting enzyme (ACE) plays an important role in cardiovascular homeostasis through angiotensin II formation and bradykinin inactivation. It has been shown that an insertion (I)/deletion (D) polymorphism of the ACE gene (ACE I/D) accounts for half of the phenotypic variance of serum ACE and that the ACE/DD genotype, which is associated with higher levels of serum ACE, is also a risk factor for myocardial infarction, especially in subjects normally considered to be at low risk. Recent reports additionally suggest that the ACE I/Dmay be associated to the anabolic response and the left ventricular growth induced by physical training, maximal oxygen consumption, and elite athletic performance.



